PT Bundamedik Tbk (BMHS.JK)
IDR 246.0
(2.5%)
IDR 246.0
(2.5%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 42.19 Billion IDR | 6.97% |
| 2022 | 39.44 Billion IDR | 26.7% |
| 2021 | 31.13 Billion IDR | 63.99% |
| 2020 | 18.98 Billion IDR | 16.99% |
| 2019 | 16.22 Billion IDR | 57.78% |
| 2018 | 10.28 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 41.78 Billion IDR | -2.34% |
| 2024 Q1 | 42.78 Billion IDR | 1.39% |
| 2024 Q3 | 48.25 Billion IDR | 15.48% |
| 2023 Q2 | 38.58 Billion IDR | -9.45% |
| 2023 Q1 | 42.61 Billion IDR | 8.03% |
| 2023 FY | 42.19 Billion IDR | 6.97% |
| 2023 Q4 | 42.19 Billion IDR | -7.85% |
| 2023 Q3 | 45.79 Billion IDR | 18.68% |
| 2022 Q2 | 41.1 Billion IDR | 45.1% |
| 2022 Q1 | 28.32 Billion IDR | -9.02% |
| 2022 FY | 39.44 Billion IDR | 26.7% |
| 2022 Q4 | 39.44 Billion IDR | 5.43% |
| 2022 Q3 | 37.41 Billion IDR | -8.96% |
| 2021 FY | 31.13 Billion IDR | 63.99% |
| 2021 Q4 | 31.13 Billion IDR | 1.11% |
| 2021 Q3 | 30.79 Billion IDR | 47.76% |
| 2021 Q2 | 20.84 Billion IDR | 0.0% |
| 2021 Q1 | - IDR | -100.0% |
| 2020 Q4 | 18.98 Billion IDR | 0.0% |
| 2020 FY | 18.98 Billion IDR | 16.99% |
| 2020 Q1 | - IDR | 0.0% |
| 2019 FY | 16.22 Billion IDR | 57.78% |
| 2018 FY | 10.28 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Metro Healthcare Indonesia Tbk | 4.77 Billion IDR | -783.105% |
| PT Medikaloka Hermina Tbk | 117.43 Billion IDR | 64.065% |
| PT Mitra Keluarga Karyasehat Tbk | 81.72 Billion IDR | 48.362% |
| PT Murni Sadar Tbk | 32.12 Billion IDR | -31.345% |
| PT Famon Awal Bros Sedaya Tbk | 54.16 Billion IDR | 22.093% |
| PT Royal Prima Tbk | 54.57 Billion IDR | 22.678% |
| PT Kedoya Adyaraya Tbk | 14.58 Billion IDR | -189.284% |
| PT Sarana Meditama Metropolitan Tbk | 53.77 Billion IDR | 21.525% |
| PT Siloam International Hospitals Tbk | 203.57 Billion IDR | 79.271% |
| PT Sejahteraraya Anugrahjaya Tbk | 48.94 Billion IDR | 13.775% |